|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2000; 35:1040-1047 © 2000 by the American College of Cardiology Foundation |
a Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Manuscript received June 7, 1999; revised manuscript received October 15, 1999, accepted November 19, 1999.
Reprint requests and correspondence: Dr. Hiroaki Shimokawa, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
shimo{at}cardiol.med.kyushu-u.ac.jp
OBJECTIVE
This study was designed to examine whether or not adenovirus-mediated gene transfer of C-type natriuretic peptide (CNP) can prevent coronary restenotic changes after balloon injury in pigs in vivo.
BACKGROUND
Gene therapy to prevent restenosis after percutaneous transluminal coronary angioplasty (PTCA) might be useful but requires a method applicable for in vivo gene delivery into the coronary artery as well as the efficient vector encoding a potent antiproliferative substance. We tested whether the adenovirus-mediated gene transfer of CNP by use of an infiltrator angioplasty balloon catheter (IABC) might prevent the coronary restenotic changes after balloon injury.
METHODS
Balloon angioplasty was performed in the left anterior descending and the left circumflex coronary artery in pigs. Immediately after the balloon injury, adenovirus solution encoding either CNP (AdCACNP) or ß-galactosidase (AdCALacZ) gene was injected with IABC into the balloon-injured coronary segments. Expression of CNP was assessed by immunohistochemical staining and cyclic guanosine 3',5'-monophosphate (cGMP) measurement. Coronary restenotic changes were evaluated by both angiographic and histological examinations.
RESULTS
CNP was highly expressed in the media and the adventitia of the coronary artery at the AdCACNP-transfected but not at the AdCALacZ-transfected segment. In the AdCALacZ-transfected segment, vascular cGMP levels tended to be reduced as compared with the untreated segment, whereas in the AdCACNP-transfected segment, vascular cGMP levels were restored. Angiographic coronary stenosis was significantly less at the AdCACNP-transfected than at the AdCALacZ-transfected segment. Histological examination revealed that this was achieved primarily by the marked inhibition of the geometric remodeling of the coronary artery by the CNP gene transfer.
CONCLUSIONS
Adenovirus-mediated CNP gene transfer with the IABC system may be a useful gene therapy to prevent restenosis after PTCA in vivo.
| ||||||||||||||||||||||||||||
This article has been cited by other articles:
|
|
 |
|
  M. N. Barber, M. Kanagasundaram, C. R. Anderson, L. M. Burrell, and R. L. Woods Vascular neutral endopeptidase inhibition improves endothelial function and reduces intimal hyperplasia Cardiovasc Res, July 1, 2006; 71(1): 179 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Clerico, F. A. Recchia, C. Passino, and M. Emdin Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H17 - H29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Kelsall, A. H. Chester, M. Amrani, and D. R.J. Singer C-Type Natriuretic Peptide Relaxes Human Coronary Artery Bypass Grafts Preconstricted by Endothelin-1 Ann. Thorac. Surg., October 1, 2005; 80(4): 1347 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pelisek, A. Kuehnl, P. H. Rolland, C. Mekkaoui, A. Fuchs, G. F. Walker, M. Ogris, E. Wagner, and S. Nikol Functional Analysis of Genomic DNA, cDNA, and Nucleotide Sequence of the Mature C-Type Natriuretic Peptide Gene in Vascular Cells Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1646 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pan, R. Gulati, C. S. Mueske, T. A. Witt, A. Lerman, J. C. Burnett Jr., and R. D. Simari Gene transfer of a novel vasoactive natriuretic peptide stimulates cGMP and lowers blood pressure in mice Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2213 - H2218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takeuchi, K. Ohmori, I. Kondo, A. Oshita, K. Shinomiya, Y. Yu, Y. Takagi, K. Mizushige, K. Kangawa, and M. Kohno Potentiation of C-type natriuretic peptide with ultrasound and microbubbles to prevent neointimal formation after vascular injury in rats Cardiovasc Res, April 1, 2003; 58(1): 231 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Morishige, H. Shimokawa, Y. Matsumoto, Y. Eto, T. Uwatoku, K. Abe, K. Sueishi, and A. Takeshita Overexpression of matrix metalloproteinase-9 promotes intravascular thrombus formation in porcine coronary arteries in vivo Cardiovasc Res, February 1, 2003; 57(2): 572 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Morishige, H. Shimokawa, Y. Eto, T. Kandabashi, K. Miyata, Y. Matsumoto, M. Hoshijima, K. Kaibuchi, and A. Takeshita Adenovirus-Mediated Transfer of Dominant-Negative Rho-Kinase Induces a Regression of Coronary Arteriosclerosis in Pigs In Vivo Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 548 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shimokawa, K. Morishige, and A. Takeshita C-type natriuretic peptide and vascular remodeling: Reply J. Am. Coll. Cardiol., January 1, 2001; 37(1): 333 - 334. [Full Text] [PDF]
|
|
|
|
|
|
Y. Eto, H. Shimokawa, J. Hiroki, K. Morishige, T. Kandabashi, Y. Matsumoto, M. Amano, M. Hoshijima, K. Kaibuchi, and A. Takeshita Gene transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1744 - H1750. [Abstract] [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
